SAB Biotherapeutics, Inc. Warrant
SABSW
SABSW
13 hedge funds and large institutions have $2.55M invested in SAB Biotherapeutics, Inc. Warrant in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
-8
Holders Change %
-38.1%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
5
Closed
8
Calls
$1.1M
Puts
–
Net Calls
+$1.1M
Net Calls Change
-$1.24M
Top Buyers
1 |
LP
LMR Partners
London,
United Kingdom
|
$1.27M |
2 |
Morgan Stanley
New York
|
$72K |